SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that Patrick S. Jones has been appointed to Fluidigm’s Board of Directors. Mr. Jones fills the vacancy created by the resignation of Jeremy Loh, which was effective on March 10, 2011. Mr. Jones will also join and chair the Board’s audit committee.

“We are excited to add Patrick to our Board,” said Sam Colella, Chairman of Fluidigm’s Board. “Patrick brings a wealth of experience and practical skills that we believe will add value and perspective to the Board as we seek to help Fluidigm grow and increase its contributions in the life science and Ag-Bio communities.”

“I am looking forward to using my international experience and semiconductor background to help Fluidigm’s management team achieve its long-term objectives,” said Mr. Jones. “Together, we hope to maximize the potential of Fluidigm’s integrated fluidic circuit solutions and bring outstanding results to our target markets and to Fluidigm investors,” he concluded.

Mr. Jones, age 66, has been a private investor since March 2001. He currently sits on the boards of several leading public companies including Epocrates, a provider of clinical solutions to healthcare professionals and interactive services to the healthcare industry; Novell, Inc., a leading enterprise infrastructure software provider; Lattice Semiconductor Corporation, a fabless semiconductor company; and Openwave Systems, a telecom infrastructure software provider. From June 1998 to March 2001, Mr. Jones was the Senior Vice President and Chief Financial Officer of Gemplus International S.A. (now GEMALTO N.V.), a provider of solutions empowered by smart cards. Prior to Gemplus, from March 1992 to June 1998, he was vice president and corporate controller at Intel Corp., a producer of microchips, computing and communications products. Prior to that, Mr. Jones served as Chief Financial Officer of LSI Logic, a semiconductor company.

Mr. Jones fills a vacancy created by the resignation of Dr. Loh, who is a Vice President (Investments) at San Francisco Centre for EDB Investments Pte Ltd, Singapore.

“We thank Jeremy for his service to Fluidigm during the critical time in which we readied ourselves for an initial public offering. His contributions to the Board helped us achieve the key milestone of becoming a publicly traded company,” said Gajus Worthington, president and chief executive officer of Fluidigm.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or chips, and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including eight different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.

For more information, please visit www.fluidigm.com.